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Abstract There is evidence that insertion of viral DNA
into a mammalian genome can lead to alterations of
methylation patterns. The aim of the present study was to
examine the presence of DNA sequences of five human
DNA viruses (assessed by PCR): JC polyoma virus (JCV),
human adenovirus (AdV), Epstein–Barr virus (EBV),
Kaposi sarcoma-associated herpesvirus (KSHV/HHV8)
and human papillomavirus (HPV) in a cohort of 186
sporadic colorectal cancers (CRCs) and related these data
with the methylation status of six CpG island methylator
phenotype (CIMP)-specific genes (MLH1, CACNA1G,
NEUROG1, IGF2, SOCS1, RUNX3) and seven cancer-
related genes markers (p16, MINT1, MINT2, MINT31, EN1,
SCTR and INHBB) assessed by methylation-specific PCR
in 186 and 134 CRC cases, respectively. The AdV, KSHV
and HPV were detected in four (2%), two (1%) and zero
CRC cases, respectively, and thus were excluded from
further analyses. Although 19% and 9% of the CRCs were
positive for EBV and JCV, respectively, no associations
between virus presence and CpG island methylation were
found after correction for multiple testing. Our results
demonstrate that the presence of DNA sequences of JCV
and EBV in CRC is unrelated to the methylation of the 13
cancer-related CpG islands and CIMP.
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Background
The process of DNA methylation in human cells is
controlled by DNA methyltransferases (DNMTs). DNMTs
catalyze the transfer of a methyl group from the methyl
donor to the 5′ position on the cytosine ring [1]. CpG island
methylation is prevalent in human sporadic cancers resulting
in the transcriptional silencing of many important genes [2].
Abberant CpG island methylation is one of the hallmarks of
sporadic colorectal cancer (CRC), and in this context, it has
been observed that a subset of CRCs exhibit an exceptionally
high frequency of methylation of discrete CpG islands
referred to as the CpG island methylator phenotype (CIMP)
[3]. Although the mechanism responsible for abberant
CpG island methylation and/or CIMP has not yet been
elucidated, there is mounting evidence that infectious
agents, such as DNAviruses, may cause aberrant methylation
in CRCs [4].
Evidence that DNAviruses influence aberrant methylation
comes from the observation that insertion of adenovirus
(AdV) DNA intoa mammaliangenomecan leadtoalterations
of methylation patterns in cellular DNA [5]. Moreover, two
recent studies have reported that Epstein–Barr virus (EBV)
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DOI 10.1007/s13277-011-0165-6transformed lymphoblastoid cell lines demonstrate altera-
tions of methylation patterns when compared to peripheral
blood leukocytes [6, 7]. Finally, abberant methylation of p16
tumour suppresor gene has been reported in Kaposi sarcoma-
associated herpesvirus (KSHV/HHV8) associated primary
efusion lymphoma. It was also demonstrated repeatedly that
various viral proteins interact with a number of host
epigenetic regulators which may contribute to alternations
in DNA methylation and histone modifications [8]. The AdV
small E1A protein binds to DNA methyltransferase 1,
increases its activity and alters global patterns of histone
modification [9]. The human papillomavirus type 16
(HPV16) E6 oncoprotein interacts with and thus inhibits
the histone acetyltransferase CBP/p300 complex, whereas
the E7 oncoprotein binds to the histone deacetylase complex
Mi2β [10]. The KSHV (HHV8) LANA protein activates
DNMT3a facilitating de novo promoter methylation [11].
The EBV latent membrane protein 1 activates all three
human DNMTs, which increases de novo promoter methyl-
ation[12]. Although none of the JC virus (JCV) proteins have
been reported to interact with any epigenetic regulator, some
previous reports have suggested a link between expression of
the JCV T-antigene and extensive promoter methylation
leading to methylator phenotype (CIMP) in CRC [13]. In
this study, we assess the presence of DNA sequences from
five viruses (JCV, EBV, AdV, KSHV (HHV8) and HPV) in
CRCs in relation to methylation of a number of cancer-related
g e n e sa sw e l la st oC I M P .
Methods
Patients
The study was performed on 186 surgically resected frozen
tissues of sporadic CRCs that were obtained between 2001
and 2008 from the 2nd Department of General and
Oncological Surgery, Wroclaw Medical University and the
Department of General Surgery, Regional Specialized
Hospital, Wroclaw.
The CRC patient’s group consisted entirely of Polish
individuals (all Caucasians). Only patients with primary,
sporadic colorectal cancer who had not received preoperative
therapy were included into the studies. Informed consent was
obtained from all patients. The study was accepted by the
Wroclaw Medical University Ethics Committee.
BRAF V600E mutation
Detection of BRAF V600E in tumour tissues was carried
out using a procedure originally described by Sapio et al.
[14]. Briefly, mutant allele-specific PCR was used to
amplify the exon 15 region of the BRAF gene. PCR
products with an expected size of 125 bp were resolved on
a 2.5% agarose–ethidium bromide gel.
Bisulphite Treatment of DNA, Methylation-Specific PCR
and CIMP
Bisulphite treatment of genomic DNA obtained from
resected frozen tumour tissues was carried out using a
procedure described by Chan et al. [15]. Approximately
50 ng of the modified DNA was amplified in a PTC 200
DNA Engine Thermal cycler (MJ Research, Inc. Waltham,
MA, USA) with primers specific to either the methylated or
unmethylated promoter sequences of the CACNA1G, IGF2,
NEUROG1, RUNX3, SOCS1, hMLH1, p16, MINT1,
MINT2, MINT31, EN1, SCTR and INHBB genes. The
primer sequences and amplification conditions of
methylation-specific PCR utilized in this study are
described elsewhere [3, 15, 16]. CIMP was defined by the
use of a specific panel of markers and criteria described by
Weisenberger et al. [3]. Briefly, after the analysis of the
methylation of a panel of five markers (CACNA1G, IGF2,
NEUROG1, RUNX3 and SOCS1), CIMP+ tumours were
defined as those with at least three methylated CIMP
markers. CIMP− tumours were defined as those with at
most two methylated CpG islands.
Viral DNA amplification
Firstly, all samples were examined for DNA integrity using
amplification of the β-globin gene. Great care was taken to
avoid specimen contamination during the course of this
investigation. Sample preparation, electrophoresis and PCR
solution preparation were conducted in physically separated
laboratory areas. The viral sequences were amplified using
a single PCR approach to avoid false positives and ensure
reliable PCR detection. For JCV, KSHV (HHV8) and EBV,
we used species-specific PCR primers [13, 17]. As the HPV
and AdV are species with a high degree of genetic
heterogeneity, we used broad-spectrum PCR primers that
permit the simultaneous amplification of a range of HPVor
AdV types in a single PCR test [18, 19]. A negative control
was included in each PCR assay. All samples were re-
examined for the presence of viral DNA. All positive
samples for EBVand JCV were confirmed using restriction
enzyme digestion.
All PCR reactions were carried out separately in a 25-μL
reaction volume containing 1× PCR buffer (Qiagen),
1.5 mmol/L MgCl2, 200 μmol/L deoxynucleoside triphos-
phate, 50 ng of genomic DNA, 0.2 μmol/L of each primer
and 0.75 U of Hot-Start DNA polymerase (Qiagen). All
PCR reactions were run under the conditions described in
the references, except for an initial denaturation period of
15 min at 95°C, which we applied in all tests. Primer
654 Tumor Biol. (2011) 32:653–659sequences and related references are shown in Table 1. All
positive controls were purchased from Advanced Biotech-
nologies Inc (Columbia, MD, USA) except of HPV, where
DNA obtained from larynx tumour positive for HPV 16
was applied (see Table 1).
Statistical analysis
The Pearson chi-squared test (if all expected cell frequen-
cies were ≥5) or Fisher’s exact test was used to test whether
the presence of a virus is associated with the methylation of
a CpG island or CIMP status. All p values were two-sided
and Bonferroni correction was taken into consideration
because of the multiple comparisons carried out in this
study. The R statistical package was used to carry out the
necessary statistical tests and calculate the confidence
intervals for the odds ratio.
Results
Study group and CIMP classification
We examined the CIMP status of 186 sporadic CRCs by
methylation-specific PCR using a CIMP-specific marker
panel (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1)
[3]. The characteristics of study group, both overall and
with respect to CIMP status, are shown in Table 2. On the
average, the CIMP+ cases tended to be older than CIMP−
cases; however, these differences did not attain statistical
significance. There were no significant differences between
CIMP− and CIMP+ cases in sex distribution. Since CIMP
was defined as the presence of at least three methylated
sites out of the five studied loci, 25% (46 out of 186) of the
tumours were classified as CIMP+. A strongly bimodal
distribution of tumours according to the number of
methylated loci was observed (Fig. 1). To examine whether
our CIMP classification was adequate, we determined the
presence of the BRAF V600E mutation and MLH1
methylation. We observed a significant association of both
the BRAF V600E mutation and MLH1 methylation with
CIMP+ tumours (odds ratio (OR)=12.33, 95% confidence
interval (CI)=4.21–41.54, P=1.8×10
−7 and OR=15.5, 95%
CI=4.54–68.65, P=2.8×10
−7, respectively). These results,
together with the strongly bimodal distribution of the
number of methylated tumours in our cohort, proved that
our CIMP classification was appropriate.
Detection of viral DNA sequences in colorectal cancers
In the current study, we analysed 186 cases of sporadic
colorectal tumours (all amplifiable with a β-globin primer
set) for the presence of five viruses (JCV, AdV, EBV,
KSHV (HHV8) and HPV) using PCR. The AdV, KSHV
and HPV were detected in four (2%), two (1%) and zero
CRC cases, respectively, and thus, these species were
excluded from the statistical analyses. Nineteen percent
(36 out of 186) cases were positive for EBV, and 9% (17
out of 186) of the cases were positive for JCV. There was
no relationship between the presence of EBV and JCV and
sex (see Table 3).
Relationship of JCV and EBV with CIMP and methylation
in CIMP markers
The overall results on the presence of EBV and JCV
according to CIMP and methylation of CIMP-specific
markers are presented in Table 3 and Fig. 1. The presence
of JCV was significantly less common in tumours with at
least one methylated CIMP-specific marker (5.6% (7 out of
Table 1 Primer sequences used in this study
Primer sequences (5′→3′) Target sequence Product
size (bp)
Positive control Reference
β-Globin GlobinF ACACAACTGTGTTCACTAGC β-Globin 225 [17]
GlobinR GGAAAATAGACCAATAGGCTG
EBV EBVF GATTTGGACCCGAAATCTGAT EBV BamHI W repeat 201 EBV B95-8 strain [17]
EBVF TCTGGGGGCTTATTCCTCTT
KSHV (HHV8) ORFK9F GTCTCTGCGCCATTCAAAAC vIRF-1 184 KSHV/HHV-8 KS-1
strain
[17]
ORFK9R CCGGACACGACAACTAAGAA
AdV Hex3 GACATGACTTTCGAGGTCGATCCCATGGA Hexon gene 139 Adenovirus-2-infected
cell DNA
[19]
Hex4 CCGGCTGAGAAGGGTGTGCGCAGGTA
HPV HPVpU-M TGTCAAAAACCGTTGTGTCC E6 and E7 regions 228∼268 HPV16-positive larynx
tumour DNA
[18]
HPVpU-31B TGCTAATTCGGTGCTACCTG
HPVpU-2R GAGCTGTCGCTTAATTGCTC
JCV JCVF ATGTATTCCACCAGGATTCCCATTCATC Large T-antigen 154 JCV MAD1 strain [13]
JCVR AGTTCTTGGAGACACCCCCTACAG
Tumor Biol. (2011) 32:653–659 655124); P=0.03) than in the group without methylated CIMP-
specific markers (16% (10 out of 62); Fig. 1). We also
examined the relationship of EBV and JCV with methyl-
ation for each CIMP-specific marker individually (Table 3).
In this analysis, EBV was inversely associated with
methylation of RUNX3 (P=0.048), and JCV was inversely
associated with methylation of CACNA1G (P=0.03). How-
ever, these associations became nonsignificant after correc-
tion for multiple testing.
Relationship of JCV and EBV with methylation
in individual CpG islands
Because JCVand EBV have been implicated in CpG island
methylation, we examined the relationship between the
presence of these two species and methylation in seven
individual CpG islands (Table 4). For this analysis, we were
able to use 134 of the 186 CRCs due to the limited
availability of DNA from the tumours. In this analysis, JCV
showed an inverse association with methylation of MINT1
(P=0.04). However, this association became nonsignificant
after correction for multiple testing
Conclusions
Epigenetic alternations play a key role in the process of
colorectal carcinogenesis [20]. The recently described
CIMP in sporadic CRC is an alternative tumorigenesis
pathway characterized by the methylation of multiple
promoter regions of tumour suppressor genes harbouring
CpG islands [3]. Paradoxically, despite dozens of studies,
the defects in the methylation machinery leading to CIMP
in CRC remain still unidentified [4].
Several lines of evidence suggest that a number of viral
proteins interact with the host’s epigenetic machinery, most
likely to evade detection by the host’s immune system [8].
Moreover, experimental approaches, such as transfection of
mammalian cells with an adenovirus, demonstrate that
insertion of viral DNA can alter the host’s DNA methyl-
ation patterns regardless of the transcription state of the
viral genome [5, 21]. Further evidence of virus-induced
alternations in host’s DNA methylation patterns was
observed in EBV transformed lymphoblastoid cells [6, 7].
Therefore, the DNA viruses such as JCV, AdV, EBV,
KSHV (HHV8) and HPV seemed to be reasonable
candidates for being a causative agent of alterations in
DNA methylation resulting in CIMP in sporadic CRC.
Table 2 Characteristics of CRC patients and control subjects
Variable All CRCs (n=186) CIMP+ CRCs (n=46) CIMP− CRCs (n=140) p value
Age (SD) 65 (±10) 68 (±11) 64 (±10)
Male (%) 105 (56) 28 (61) 77 (56)
Female (%) 81 (44) 18 (39) 63 (44)
hMLH1 (%) 2.8×10
−7a
Positive 19 (10) 15 (33) 4 (3)
Negative 167 (90) 31 (67) 136 (97)
BRAF V600E (%) 1.8×10
−7a
Positive 23 (12) 17 (37) 6 (4)
Negative 163 (88) 29 (63) 134 (96)
Right-sided 24 (21) 10 (37) 14 (18) 0.02
b
Left-sided 85 (79) 17 (63) 68 (82)
No info 77
SD standard deviation
ap value refers to Fisher’s exact test
bp value refers to Pearson’s chi-squared test
Fig. 1 Bimodal distribution of the number of methylated CIMP-
specific markers in 186 colorectal tumour specimens with relation to
EBV and JCV presence
656 Tumor Biol. (2011) 32:653–659In the present study, AdV and KSHV (HHV8) were
detected in four and two CRC cases, respectively. Hence,
these species were excluded from further analyses. Of note,
the very low frequency of infections in our CRC group by
these species are in agreement with those reported by
Knösel et al. [22], who studied various infectious pathogens
in Crohn’s disease.
In our CRC group, no positive signals (0 out of 186)
were obtained for HPV. HPV DNA has been detected in
CRCs by others with a frequency ranging from 50% to 80%
[23–25]. Interestingly, in the all of above-mentioned
reports, a nested PCR was employed to detect HPV. In
our opinion, this detection technique is likely to introduce a
high rate of false positives or the detection of insignificant
virus load in the sample, which leads to overestimation of
virus presence in the sample; therefore, we decided to stay
in line with a single PCR approach for all virus species
investigated in this study. In agreement with our strategy,
the results of Atula et al. [26] suggest that HPV DNA
detected by nested PCR in laryngeal carcinoma cell lines is
likely to relate to the presence of minimal amounts of HPV
(20 HPV-positive cells among 10
6 tumour cells) suggesting
non-clonal persistence of HPV in laryngeal carcinomas.
Most importantly, we were able to amplify HPV DNA from
Marker Total EBV+ (%) EBV− (%) p value JCV+ (%) JCV− (%) p value
186 36 (19) 150 (81) 17 (9) 169 (91)
Male 105 18 (17) 87 (83) 0.46 10 (10) 95 (90) 1.00
Female 81 18 (22) 63 (78) 7 (9) 74 (91)
CIMP+ 46 6 (13) 40 (87) 0.21 3 (7) 43 (93) 0.57
CIMP− 140 30 (21) 110 (79) 14 (10) 126 (90)
n CpG≥1 124 24 (19) 100 (81) 1.00 7 (6) 117 (94) 0.03
n CpG=0 62 12 (19) 50 (81) 10 (16) 52 (84)
BRAF (+) 23 1 (4) 22 (96) 0.08
a 0 (0) 23 (100) 0.13
a
BRAF (−) 163 35 (21) 128 (79) 17 (10) 146 (90)
MLH (+) 19 2 (11) 17 (89) 0.54
a 1 (5) 18 (95) 0.70
a
MLH (−) 167 34 (20) 133 (80) 16 (10) 151 (90)
CACNA1G (+) 69 9 (13) 60 (87) 0.12 2 (3) 67 (97) 0.03
CACNA1G (−) 117 27 (23) 90 (77) 15 (13) 102 (87)
IGF2 (+) 44 5 (11) 39 (89) 0.19 4 (9) 40 (91) 1.00
IGF2 (−) 142 31 (12) 111 (88) 13 (9) 129 (91)
NEUROG1 (+) 72 16 (22) 56 (78) 0.45 3 (4) 69 (96) 0.07
NEUROG1 (−) 114 20 (18) 94 (72) 14 (12) 100 (88)
RUNX3 (+) 62 7 (11) 55 (89) 0.048 3 (5) 59 (95) 0.18
RUNX3(−) 124 29 (23) 95 (77) 14 (11) 110 (89)
SOCS1 (+) 51 10 (20) 41 (80) 1.00 4 (8) 47 (92) 1.00
SOCS1 (−) 135 26 (19) 109 (81) 13 (10) 122 (90)
Table 3 Frequency of JCV and
EBV in 186 colorectal cancers
in relation to CIMP and meth-
ylation of CIMP markers
ap value refers to Fisher’s exact
test
Marker Total EBV+ (%) EBV− (%) p value JCV+ (%) JCV− (%) p value
134 22 (16) 112 (84) 0.80 13 (10) 121 (90) 0.22
p16 (+) 44 8 (18) 36 (82) 2 (5) 42 (95)
p16 (−) 90 14 (16) 76 (84) 0.59 11 (12) 79 (88) 0.04
MINT1 (+) 34 4 (12) 30 (88) 0 (0) 34 (100)
MINT1 (−) 100 18 (18) 82 (82) 0.23 13 (13) 87 (87) 1.00
MINT2 (+) 53 6 (11) 47 (89) 5 (9) 48 (91)
MINT2 (−) 81 16 (20) 65 (80) 0.46 8 (10) 73 (90) 0.55
MINT31 (+) 49 6 (12) 43 (88) 6 (12) 43 (88)
MINT31 (−) 85 16 (19) 69 (81) 0.80 7 (8) 78 (92) 0.76
EN1 (+) 45 8 (18) 37 (82) 5 (11) 40 (89)
EN1 (−) 89 14 (16) 75 (84) 1.00 8 (9) 81 (91) 0.69
SCTR (+) 113 19 (17) 94 (83) 12 (11) 101 (89)
SCTR (−) 21 3 (14) 18 (86) 0.61 1 (5) 20 (95) 1.00
INHBB (+) 38 5 (13) 33 (87) 4 (11) 34 (89)
INHBB (−) 96 17 (18) 79 (82) 9 (9) 87 (91)
Table 4 Frequency of JCV and
EBV in 134 colorectal cancers
in relation to methylation of
individual cancer-related CpG
islands
Tumor Biol. (2011) 32:653–659 657larynx cancer samples by our PCR approach (data not
shown) which further suggests lack or minimal amounts of
HPV copies in our CRC cohort.
Of the other viruses examined, EBV was the most
frequent pathogen (19% of the cases). Few papers have
been also published on the presence of EBV in CRCs,
moreover with contradicting results. EBV DNA has been
detected in CRCs with a frequency ranging from 0% to
19% [27–29]. In great majority of above-mentioned studies,
EBV has been detected by using in situ hybridisation of the
small EBV-encoded RNA1 (EBER1) which is believed to
be consistently expressed in EBV infection. However, an
EBER-negative form of EBV infection has been observed
in breast cancers and hepatocellular carcinoma, and there-
fore, a lack of detectable EBNA1 expression cannot be
taken as proof of absence of the virus [30, 31]. Since in the
present study we used DNA obtained from resected
tumours, it is possible that some of the EBV-positive
signals reflect the presence of tumour-infiltrating lympho-
cytes (TILs) in the tumour stroma that carry EBV rather
than the presence of EBV-positive tumour cells. However,
Yoshiyama et al. [32] and others reported that EBV is able
to infect epithelial cell lines in vitro only by co-culture with
EBV-infected B cells; therefore, the contribution of EBV-
positive TILs (as possible EBV transmitters) in patho-
genesis of colon cancer cannot be completely excluded
[33]. In general, EBV was not associated either with the
CIMP phenotype or methylation of any of the individual
CpG islands studied, except for an inverse association with
methylation in one of the CIMP-specific markers (RUNX3;
nonsignificant after correction for multiple testing).
ThesecondmostfrequentvirusinourCRCgroupwasJCV
(9% of the cases). As in the case of prevalence of HPV in
CRCs, the papers published on the presence of JCV T-antigen
sequence in CRCs display contradictory results with frequen-
cies ranging from 0% in Italian and Spanish study, through
26% in Japanese cases to 77% in American patients [13, 34–
36]. Given the all above-cited studies based on relatively
similar PCR approaches, the discrepancies of JCV frequen-
cies in CRC may reflect ethnic-dependent epidemiology of
JCVor lack of reliable and reproducible test for the detection
of JCV DNA [37]. A previous study by Goel et al. [13]
reported an association between JCV T-antigen expression
and methylation of the promoter region of various cancer-
related genes in colorectal cancer. Goel et al. [13]a l s o
hypothesized that the JCV T-antigen may be responsible for
induction of the methylator phenotype in CRC. Contrary to
these results, we found that the presence of JCV T-antigen
sequence was less common in tumours with at least one
methylated CIMP-specific marker. Moreover, we showed
that among the CRC cases, the presence of JCV T-antigen
sequence was inversely associated with methylation in two
CIMP-related genes (CACNA1G and MINT1). Although
these associations became nonsignificant after correction
for multiple testing, it did not escape our attention that the
presence of JCV T-antigen sequence shows some tendency
towards unmethylated CpG islands. Similar results were
presented in a very recent paper by Nosho et al. [38], who
observed an inverse association of JCV T-antigen expression
with CIMP and a lack of association with methylation in 16
genes in a large sample of CRCs. Interestingly, some recent
reports show very strong evidence that JCV T-antigen
interacts with p53 and Rb family proteins and therefore
may induce chromosomal instability (CIN), which is a
largely independent from the CIMP pathway in colorectal
carcinogenesis [39, 40]. The independence of the CIN and
CIMP pathways in sporadic CRC manifests itself via the
high level of chromosomal aberrations in tumours with none
of the CIMP markers methylated [41]. The more common
presence of JCV in a group of CRCs without any CIMP
marker methylated revealed by our study provides some
support to the notion that JCV may contribute to CIN in a
fraction of CRC cases [38].
A potential limitation of this study is that DNA
methylation investigation was limited to several CpG
islands; therefore, the influence of presence of JCV and
EBV on DNA methylation in CRC needs to be further
elucidated on the genome-wide scale. Finally, further
research is needed to assess the relationship between virus
load and DNA methylation in CRC.
In summary, our study provides no evidence of involve-
ment of AdV, KSHV (HHV8) and HPV in pathogenesis of
CRC in Polish population. The presence of JCV and EBV
sequences in CRCs was not related to methylation of the 13
cancer-related CpG islands and CIMP.
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